FDA Approves Ziextenzo (pegfilgrastim-bmez), a Biosimilar to Neulasta Print this page Holzkirchen, Nov. 5, 2019 – Sandoz, a Novartis division and a global leader in biosimilars, today announced that the US Food and Drug Administration (FDA) approved its biosimilar Ziextenzo (pegfilgrastim-bmez). Sandoz biosimilar pegfilgrastim has been approved and marketed in Europe as Ziextenzo® (pegfilgrastim) since… Read More »
November 5th, 2019 Medgadget Editors Anesthesiology, Critical Care, Emergency Medicine, Medicine, Surgery Med-botics, a firm based in Colorado Springs, won FDA Breakthrough Device status for its Oxalert EPO (Enhanced Pulse Oximeter), a device developed to prevent respiratory arrest from opioid overdoses. Post-op patients and others on heavy opioid therapy can stop breathing, which can lead… Read More »
We see patients at two locations in Quincy and Hannibal. Weeks two to three: Continue with a liquid diet, but you can now include up to 20 grams of protein per day. The stage 1 diet that is provided at hospital immediately after surgery. It should help reduce fears that bariatric surgery increases the risk… Read More »
Haven, the Boston-based healthcare company formed by Amazon, JPMorgan Chase & Co. and Berkshire Hathaway, is testing a new health plan for bank employees, a JPMorgan spokesman has confirmed. The pilot is taking place in two states, confirmed Andrew Gray, managing director corporate communications of JPMorgan Chase. The insurance pilot is being tested in Ohio… Read More »